Sandhill Capital Partners LLC Athenex, Inc. Transaction History

Sandhill Capital Partners LLC

  • $1.35 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$9.44 - $19.8 $318,817 - $668,705
-33,773 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$13.53 - $17.47 $456,948 - $590,014
33,773 New
33,773 $574,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Sandhill Capital Partners LLC Portfolio

Follow Sandhill Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email